                            NIH Public Access
                            Author Manuscript
                            J Neurochem. Author manuscript; available PMC 2010 April 20.
                           Published final edited form 
NIH-PA Author Manuscript




                            J Neurochem. 2010 March ; 112(6): 1593â€“1604. doi:10.1111/j.1471-4159.2010.06568.x.



                           MKK6 binds regulates expression Parkinsonâ€™s disease-
                           related protein LRRK2

                           Cindy H. Hsu1, Diane Chan1, Elisa Greggio2, Shamol Saha1, Maria D. Guillily1, Andrew
                           Ferree1, Kesav Raghavan1, Grace C. Shen1, Lilach Segal1, Hoon Ryu3, Mark R. Cookson2,
                           Benjamin Wolozin1,*
                           1Department Pharmacology, Boston University School Medicine, Boston, MA 02118-2526

                           2Laboratory    Neurogenetics, National Institute Aging, Bethesda, MD 20892
                           3Department      Neurology, Boston University School Medicine, Boston, MA 02118-2526

                           Abstract
NIH-PA Author Manuscript




                                Mutations leucine-rich repeat kinase 2 (LRRK2) prevalent causes late-onset Parkinsonâ€™s
                                disease (PD).  LRRK2 binds mitogen-activated protein kinase (MAPK)
                                kinases MKK3, 6, 7, LRRK2 able phosphorylate MKK3, 6 7. 
                                expression LRRK2 MKK6 increased steady state levels protein                                 observed expression protein  expression increased levels MKK6                                 membrane cytoplasm. increased expression LRRK2 MKK6
                                requires MKK6 activity. disease-linked LRRK2 mutations, G2019S, R1441C I2020T,
                                enhance binding LRRK2 MKK6. interaction supported vivo studies                                 C. elegans. RNAi knockdown C. elegans endogenous orthologs MKK6 p38, sek-1
                                pmk-1, abolishes LRRK2-mediated protection mitochondrial stress. results
                                confirmed deletion sek-1 C. elegans. data demonstrate MKKs                                 LRRK2 function similar biological pathways, support role LRRK2 modulating                                 cellular stress response.


                           Keywords
                                MAP kinase; phosphorylation; C. elegans; JNK; p38; membrane
NIH-PA Author Manuscript




                           INTRODUCTION
                                            Parkinsonâ€™s disease (PD) common neurodegenerative movement disorder
                                            (Olanow et al. 2009). majority PD cases sporadic, identification                                             genes responsible familial parkinsonism enhanced understanding                                             pathogenesis PD. Autosomal-dominant mutations leucine-rich repeat kinase 2
                                            (LRRK2) particularly interesting associated sporadic PD                                             familial form PD resembles sporadic PD (Zimprich et al. 2004). majority                                             LRRK2 cases exhibit pathological findings consisting Î±-synuclein inclusions,                                             pathological hallmark PD (Zimprich et al. 2004).  cases LRRK2
                                            mutations exhibit pleiomorphic pathology, including tau inclusions, inclusions
                                            (Zimprich et al. 2004).



                           *Correspondence  Benjamin Wolozin, M.D., Ph.D., Department Pharmacology, Boston University School Medicine, 715
                           Albany St, R-614, Boston, MA 02118-2526, 617-414-2652 (Phone), 617-414-2651 (Fax), bwolozin@bu.edu.
                            Hsu et al.                                                                                              Page 2


                                           LRRK2 protein conserved domains including: leucine-rich domain (LRR),
                                           Roc GTPase domain, COR (carboxy-terminal Ras) domain, kinase domain,                                            WD40 domain carboxy-terminal (Zimprich et al. 2004, Greggio & Cookson 2009).
NIH-PA Author Manuscript




                                           G2019S familial mutation leads increased LRRK2 autophosphorylation kinase
                                           activity (West et al. 2005, Smith et al. 2005, Smith et al. 2006, Greggio et al. 2006).                                            mutations appear affect kinase activity lesser extent (West et al. 2005, Smith et al.
                                           2005, Smith et al. 2006, Gloeckner et al. 2009, Jaleel et al. 2007). expression                                            mutants lead increased caspase-dependent toxicity primary neurons
                                           (Macleod et al. 2006, Iaccarino et al. 2007, Ho et al. 2009). Missense mutations causing
                                           disruption LRRK2 GTPase activity shown lead cell death (Ito et al.
                                           2007, Lewis et al. 2007, Li et al. 2007). addition, LRRK2 appears regulate neurite
                                           morphology rodents, human neuronal cell lines (Macleod et al. 2006, Plowey et al.
                                           2008).  exact mechanism LRRK2 lead pathogenesis PD
                                           remains critical unanswered question.

                                           kinase domain LRRK2 shares homology receptor interacting protein kinases
                                           (RIPs) mixed lineage kinases (MLKs) (Greggio & Cookson 2009). RIP kinases,                                            RIP-1, mediate signaling death receptors, activate stress kinases (JNK p38)
                                           NF-kB (Festjens et al. 2007). RIP kinase family particularly interesting                                            light recent observations LRRK2 mediates signaling death receptor
                                           protein Fas binding protein (Ho et al. 2009). MLKs family serine/threonine protein
NIH-PA Author Manuscript




                                           kinases function upstream MAPK signaling cascades (Silva et al. 2005).                                            MLK family kinases activate c-jun amino-terminal kinase (JNK) pathway                                            phosphorylating MAPK kinase 4 7 (MKK4 MKK7), p38 pathway                                            phosphorylating MAPK kinase 3 6 (MKK3 MKK6). MKKs                                            recruited multi-protein complex scaffold proteins JNK Interacting Proteins (JIPs)
                                           1â€“3 (Gallo & Johnson 2002). homology LRRK2, RIPs MLKs lead                                            hypothesize LRRK2 interact MKKs manner similar kinases.

                                           data demonstrate interactions LRRK2 MKK 3, 6, 7. observed                                            LRRK2 binds MKKs COR kinase domains, phosphorylates                                            MKKs. G2019S, R1441C I2020T LRRK2 mutations increase association                                            LRRK2 MKK6. Binding LRRK2 MKK6 associated increased levels                                            proteins plasma membrane cytoplasm, change dependent                                            activity MKK6. LRRK2 able phosphorylate MKK6. validated importance                                            MKK6 LRRK2 function mitochondrial stress using RNAi knockdown                                            deletion transgenic LRRK2 C. elegans. data suggest intriguing mechanism                                            MKK6 regulate function LRRK2, suggests role LRRK2                                            stress response.
NIH-PA Author Manuscript




                              MATERIALS METHODS
                              Constructs
                                           Wild-type (WT) mutant LRRK2 V5 tagged constructs generated described
                                           Greggio et al. (Greggio et al. 2006). pathogenic, kinase dead, deletion LRRK2
                                           constructs utilized study illustrated schematically Fig. S1. pRSV-Flag-MKK3,
                                           dominant negative pRSV-Flag-MKK3 (Ala), pcDNA3-Flag-MKK6, dominant negative
                                           pcDNA3-Flag-MKK6 (K82A), pcDNA3-Flag-MKK7, dominant negative pcDNA3-
                                           Flag-MKK7 (K82A) generous gifts Dr. Roger Davis (University                                            Massachusetts). Recombinant MKK3, 6 7 purchased R&D Systems.




                                                J Neurochem. Author manuscript; available PMC 2010 April 20.
                            Hsu et al.                                                                                                Page 3


                              Cell culture
                                             HEK-293 HEK-293FT cells maintained DMEM (Invitrogen) supplemented                                              10  FBS (Atlanta Biologicals), 1Ã— non-essential amino acids, penicillin (100 units/ml), NIH-PA Author Manuscript




                                             streptomycin (100 Âµg/ml). Transfections performed using FuGENE 6.0 reagent (Roche
                                             Applied Science) HEK-293 cells Lipofectamine 2000 (Invitrogen) HEK-293FT
                                             cells.

                              Quantitative real-time PCR assay
                                             HEK-293 cells transfected LRRK2 constructs RNA extracted 8 hours
                                             post-transfection using Qiagene RNeasy mini kit. Intact RNA checked running                                              1.0  agarose gel quantified spectrometrically (NanoDrop ND-1000) proceeding
                                             subsequent steps. 1 Âµg total RNA reverse-transcribed using iScript cDNA
                                             synthesis kit (Bio-Rad) according manufacturerâ€™s instructions. Real-time PCR                                              performed MyiQâ„¢ Detection (Bio-Rad) using iQ SYBR Green supermix.
                                             Expression levels target gene calculated 2-Î”Î”CT method (Livak &
                                             Schmittgen 2001). analyses performed triplicates. Primers used c-jun                                              5'-GGAACAGGTGGCACAGCTTAAACA-3' (forward) 5'-
                                             TTGCAACTGCTGCGTTAGCATGAG-3' (reverse) GAPDH                                              5'TGGCCAAGGTCATCCATGACAACT-3' (forward) 5'-
                                             CACAGTCTTCTGGGTGGCAGTGAT-3' (reverse).
NIH-PA Author Manuscript




                              immunoprecipitation
                                             HEK-293FT cells transfected V5 tagged LRRK2 Flag-tagged MKK
                                             constructs, harvested immunoprecipitation (IP) buffer consisted 150 mM NaCl, 20
                                             mM Hepes (pH = 7.4), 50 mM Î²-glycerophosphate, 5 mM sodium fluoride, 1  Triton
                                             X-100, 10  glycerol, 2 mM EGTA, 1 mM sodium orthovanadate, 1Ã— protease inhibitor
                                             cocktail (Sigma) LRRK2-MKK3 immunoprecipitation 0.5  Triton-X, 1 mM
                                             EDTA 1X PBS 1X protease inhibitor cocktail (Sigma) 
                                             immunoprecipitations. lysates rotated 4 Â°C 30 minutes followed                                              centrifugation 13,000g 10 minutes. supernatant pre-cleared Protein G
                                             Sepharose 4 Fast Flow (Amersham) followed addition appropriate antibody                                              rotated overnight 4 Â°C. Protein G Sepharose added pull antibody pre-
                                             complex. Sepharose beads stringently washed times IP buffer                                              50 mM Tris (pH = 8) wash buffer. immunoprecipitation proteins eluted                                              lithium dodecyl sulphate (LDS) sample buffer (Invitrogen) heating 95 Â°C 3
                                             minutes. Immunoprecipitates resolved 3â€“8  NuPAGE Tris-Acetate 4â€“20  Tris-
                                             Glycine gels (Invitrogen) analyzed western blot. Antibodies purchased                                              Sigma (V5, Flag, c-Myc, actin), Calbiochem (Calnexin), Biodesign (GAPDH).
NIH-PA Author Manuscript




                                             immunoaffinity chromatography, lysates (5 mg) generated using IP buffer,
                                             loaded column containing 400 Âµl anti-V5-agarose (Sigma), washed IP buffer
                                             followed 50 mM Tris (pH 8) wash buffer, eluted V5-peptide (1 mg/ml,
                                             Sigma). Fractions analyzed immunoblot described 

                              Subcellular fractionation
                                             HEK-293FT cells transfected appropriate constructs 48 hours, washed
                                             cold 1Ã— PBS, lysed relaxation buffer consisted 100 mM KCl, 3 mM NaCl,
                                             3.5 mM MgCl2, 1.25 mM EGTA, 10 mM PIPES, 1Ã— protease inhibitor cocktail.                                              lysates centrifuged 500g 5 minutes eliminate cellular debris,                                              supernatant centrifuged 100,000g 1 hour 4 Â°C separate cytosolic
                                             fraction. pellets solublized 200 Âµl relaxation buffer obtain membrane


                                                  J Neurochem. Author manuscript; available PMC 2010 April 20.
                            Hsu et al.                                                                                             Page 4


                                           fraction. Equal amounts lysate loaded resolved 3â€“8  NuPAGE Tris-Acetate
                                           4â€“20  Tris-Glycine gels western blotting.
NIH-PA Author Manuscript




                              Kinase assays
                                           Kinase assays performed described Gloeckner et al (Gloeckner et al. 2009,
                                           Greggio et al. 2007). Recombinant LRRK2 obtained Invitrogen. MKKs                                            generated transfecting 293FT cells Flag-MKK constructs, immunopurifying                                            Flag-MKK anti-Flag M2 agarose eluting Flag peptide (25 Âµg peptide/run,
                                           using 10 cm dish purification). 25 nM recombinant LRRK2 (Invitrogen)                                            incubated ~ 1ÂµM Flag-tagged MKK substrate protein 30 ÂµL assay buffer (25 mM
                                           Trisâ€“HCl pH 7.5, 5 mM beta-glycerophosphate, 2 mM DTT, 0.1 mM Na3VO4, 10 mM
                                           MgCl2, Cell Signaling) supplemented 5 ÂµCi Î³33P-ATP (3000 Ci/mmol; PerkinElmer
                                           Life Sciences). reaction mix incubated 1 h 30Â°C. reaction stopped                                            addition 10 ÂµL 5 Ã— Laemmli buffer samples incubated 5 min 95Â°C prior                                            SDS gel-electrophoresis subsequent immunoblotting, needed.

                              Immunocytochemistry
                                           HEK-293FT cells plated glass coverslips transfected Lipofectamine 2000                                            50  confluency. 48 hours, transfected cells fixed 4  paraformaldehyde
                                           1Ã— PBS 10 minutes room temperature. cells washed 3 times PBS 5
NIH-PA Author Manuscript




                                           minutes incubated 0.3  triton X-100 PBS 1  bovine serum
                                           albumin (BSA) 1 hour room temperature. cells incubated 1:1000
                                           dilution anti-V5 anti-FLAG antibodies overnight room temperature. washing
                                           cells 3 times PBS 5 minutes  cells incubated 1:750 dilution
                                           FITC-conjugated goat anti-rabbit antibody (Jackson ImmunoResearch) 1Ã— PBS.                                            washes repeated 1Ã— PBS cells incubated 1:750 dilution Texas
                                           Red conjugated donkey anti-mouse antibody (Jackson ImmunoResearch). washing                                            cells 3 times 1Ã— PBS 5 minutes  embedded Antifade DAPI gel
                                           mounting medium (Invitrogen). Antibody N-terminus APP (22C11, Calbiochem)
                                           used marker cell membranes.

                              Microscopy
                                           cells visualized dimensional multiple wavelength fluorescence
                                           microscopy using Olympus IX70 microscope equipped SoftWorÃ— 3.3.6, Deltavision
                                           90000 (Applied Precision) DAPI, FITC Texas Red fluorescence room temperature
                                           using oil immersion 60Ã— Olympus PlanApo objective (aperture set 1.40). images
                                           captured using HP CoolSNAP camera, deconvolved using SoftWorÃ— software
                                           (Applied Precision), examined single sections projections entire stack
NIH-PA Author Manuscript




                                           optical sections. images processed using Adobe Photoshop CS2.

                                           C. elegansâ€”Transgenic LRRK2 C. elegans lines generated described Saha et
                                           al (Saha et al. 2009). WT LRRK2 wlzIs2 line crossed sek-1 [km4] line                                            bred homozygocity (Tanaka-Hino et al. 2002). presence LRRK2 km4
                                           deletion validated PCR. RNAi knockdown performed according Kamath et
                                           al. (Kamath et al. 2001). Non-transgenic Bristol N2 WT LRRK2 worms allowed                                            lay eggs 3 hours NGM plates containing OP50 bacteria. 3 days, synchronized
                                           young adult nematodes moved NGM plates feed HT115 bacteria containing
                                           vector PL4440 double-stranded RNAi expressing plasmid 2 additional
                                           days. 25 adult worms moved triplicate plates containing 25 ÂµM rotenone                                            HT115 bacteria. NGM plates 1 mM IPTG constant induction                                            RNAs. Nose-poke assays performed identify quantify live worms 4 days.



                                                J Neurochem. Author manuscript; available PMC 2010 April 20.
                            Hsu et al.                                                                                            Page 5


                              Statistical analysis
                                           data expressed mean Â± SEM graphed using Excel Prism (GraphPad).
                                           way ANOVA Tukeyâ€™s post hoc tests performed identify statistically
NIH-PA Author Manuscript




                                           significant differences using InStat (GraphPad).

                              RESULTS
                              LRRK2 binds MKK3 6
                                           HEK-293FT cells transiently transfected V5 tagged WT LRRK2 Flag-
                                           tagged MKK3 MKK6. Protein complexes containing MKK6 (Fig. 1  MKK3 (SI Fig.
                                           S2  evident immunoprecipitation LRRK2 MKKs. Interestingly,
                                           transfecting LRRK2 MKK6 increased total levels MKK6, shown                                            input lanes Fig. 1A & C. Analysis LRRK2 deletion mutants demonstrated LRRK2
                                           COR kinase domains essential sufficient binding MKK6 (Fig. 1 B)                                            MKK3 (Fig. S2 B). contrast, LRR domain required binding. Selectivity
                                           apparent study MKK mutants, dominant negative MKK
                                           mutation K82A strongly reduced binding LRRK2 MKK6 (Fig. 1 C) MKK3
                                           (Fig. S2 D). Finally, examined LRRK2 associated endogenous MKK6.
                                           HEK-293 FT cells transfected vector V5-tagged wild-type LRRK2.
                                           Lysates collected immunoprecipitation buffer, passed anti-V5 column
NIH-PA Author Manuscript




                                           eluted V5-peptide. Endogenous MKK6 readily apparent eluate V5-
                                           LRRK2 transfected lysates absent vector-transfected lysates (Fig.1D).
                                           Immuboblots cell lysates immunoprecipitation showed increase                                            endogenous MKK6 levels transfection LRRK2 (Fig. 1D), similar                                            increase observed Figures 1A & C. results suggest LRRK2 interacts                                            MKK6 MKK3.

                              LRRK2 binds MKK7 MKK4
                                           JNK pathway regulated MKK4 MKK7, hypothesize LRRK2
                                           interact MKKs. immunoprecipitation experiments demonstrated
                                           LRRK2 binds MKK7 MKK4 (Fig. 2 . LRRK2 kinase COR
                                           domains essential sufficient interaction MKK7 (Fig. 2 B), similar                                            observed MKK6 MKK3. dominant negative K82A mutation completely
                                           abolished binding MKK7 LRRK2 (Fig. 2 C), suggesting similar                                            interaction MKK6 LRRK2, LRRK2/MKK7 interaction dependent                                            activation MKK7. observed transfecting LRRK2 MKK4 7                                            associated increase MKK levels similar seen MKK6 (Fig. 2A & C).
NIH-PA Author Manuscript




                              LRRK2 weakly phosphorylates MKKs
                                           association LRRK2 MKKs led hypothesize families                                            kinases potentially mutual substrates. Recent studies indicate LRRK2
                                           phosphorylates recombinant MKKs (Gloeckner et al. 2009). test hypothesis,
                                           radioactive kinase assays performed using Flag-tagged MKK3, 6 7
                                           immunoprecipitated HEK-293FT cells recombinant LRRK2 (fig. 3A & B).
                                           Phosphorylation measured using 32P-ATP (fig. 3A, C & D). Incubating WT G2019S
                                           LRRK2 MKK3, 6 7 moderately stimulated phosphorylation MKK3 MKK7,
                                           marginal effects MKK6 (fig. 3C). Phosphorylation required LRRK2 kinase
                                           activity kinase dead LRRK2 able stimulate MKK phosphorylation (fig.
                                           3A & C). Interestingly, MKKs appeared reduce autophosphorylation                                            G2019S LRRK2 (fig. 3D). data provide evidence LRRK2 modify MKK
                                           function, vice-versa. phosphorylation modest, changes 

                                                J Neurochem. Author manuscript; available PMC 2010 April 20.
                            Hsu et al.                                                                                             Page 6


                                          phosphorylation downstream kinases, JNK p38, observed 
                                          expressing WT G2019S LRRK2 (data shown), consistent prior reports
                                          (Liou et al. 2008).
NIH-PA Author Manuscript




                              expressing LRRK2 MKK6 increases levels MKK6 membrane                               cytoplasm
                                          activity MAPK cascades regulated factors phosphorylation.
                                          regulation MAPK specificity frequently requires tethering appropriate kinases
                                          scaffold proteins form stimuli-specific module, module targeted
                                          appropriate subcellular compartment activation downstream signals (Garrington
                                          & Johnson 1999). hypothesized LRRK2 act scaffold protein                                           recruit MKKs specific subcellular compartments. test hypothesis, investigated
                                          expression LRRK2 altered distribution MKK6. HEK-293FT cells                                           transfected WT LRRK2 WT dominant negative MKK6, lysates
                                          fractionated cytosolic membrane fractions (Fig. 4A). Expressing WT LRRK2
                                          increased levels MKK6 membrane fraction approximately 4-fold (Fig. 4 & B).
                                          Total MKK6 levels increased expression LRRK2, increase
                                          (~50 ) change seen membrane fraction (Fig. 4A). LRRK2
                                          expression appeared somewhat reduced expressed dominant negative
                                          MKK6 compared WT MKK6, occurred cytoplasm membrane
                                          fractions (fig. 4A). examine subcellular localization MKKs, focused NIH-PA Author Manuscript




                                          interaction MKK6 using imaging, performed immunocytochemistry utilizing                                           antibody N-terminus amyloid precursor protein (22C11) label membrane.
                                          localization MKK6 membrane marker (amyloid precursor protein) increased
                                          cells transfected LRRK2 MKK6, compared cells expressing MKK6                                           (fig. 4C); pattern reactivity suggested localization plasma membrane.

                                          examined expression MKK6 changed subcellular localization
                                          LRRK2. fractionation studies showed increases cytoplasmic membrane
                                          levels LRRK2 (fig. 4A). proceeded examine question                                           Immunocytochemistry. Cells expressed LRRK2 MKK6 showed pattern                                           reactivity distinct â€œrimâ€? reactivity, compared cells expressing LRRK2
                                          cells expressing dnMKK6 (fig. 5). data consistent increased membrane
                                          binding, MKK6 increases total levels LRRK2, microscopy                                           rule changes result simply increased expression.

                              MKK6 p38 orthologs C. elegans required LRRK2 function
                                          gain insight role MKK6 LRRK2 function vivo examine NIH-PA Author Manuscript




                                          endogenous MKKs regulated LRRK2 function neurons, utilized transgenic C. elegans
                                          lines express human WT LRRK2 driven synaptobrevin promoter,                                           neuron-specific promoter. recently generated lines C. elegans expressing LRRK2                                           showed LRRK2 complements function C. elegans ortholog, lrk-1                                           rotenone-protection assay (Saha et al. 2009). Nematode lines expressing WT LRRK2                                           strongly protected toxicity rotenone, mitochondrial complex inhibitor (Saha et
                                          al. 2009). strong phenotype associated LRRK2 expression provides robust assay
                                          test genetic pathways mediating LRRK2 function.

                                          RNAi used knock C. elegans MKK6/3 ortholog sek-1 downstream
                                          target, p38 MAPK ortholog pmk-1. Non-transgenic Bristol N2 WT LRRK2 C. elegans
                                          exposed RNAi feeding vectors coding sek-1 pmk-1 exposed 25
                                          ÂµM rotenone 4 days maintaining RNAi treatment. observed nematodes
                                          expressing LRRK2 protected rotenone (Fig. 6), consistent 

                                               J Neurochem. Author manuscript; available PMC 2010 April 20.
                            Hsu et al.                                                                                            Page 7


                                         prior results (Saha et al. 2009). Knockdown sek-1 (Fig. 6A) pmk-1 (Fig. 6B)
                                         completely abolished ability WT LRRK2 protect C. elegans rotenone,
                                         control vector effect. Analysis mRNA levels real time PCR
NIH-PA Author Manuscript




                                         indicated 60 Â± 9  (P < 0.01, N=3) decrease expression sek-1 transcript                                          similar decrease pmk-1. role MKK3/6 (sek-1) confirmed deleting                                          sek-1 gene WT LRRK2 wlzIs2 crossing sek-1 [km4] C. elegans line,
                                         carries deletion sek-1 exons 4â€“6 (www.wormbase.org), breeding                                          homozygocity (Tanaka-Hino et al. 2002). effects rotenone toxicity                                          examined. LRRK2 wlzIs2 line showed strong resistance rotenone toxicity,                                          LRRK2/sek-1 [km4] line showed protection (Fig. 6C). Finally, examined                                          endogenous lrk-1 required protection sek1 pmk-1. determine sek-1
                                         pmk-1 required lrk-1 modify rotenone toxicity, examined effects sek-1                                          pmk-1 knockdown lrk-1 [km17] C. elegans line deletion lrk-1. lrk-1
                                         [km17] line highly sensitive rotenone (25 ÂµM, 4 days), expected. addition,
                                         pmk-1 knockdown provided protection effect sek-1 knockdown                                          observed N2 line contains active lrk-1 (fig. 6D lrk-1[km17] line, vs.
                                         fig. 6A&B lines containing lrk-1). Taken data suggest lrk-1                                          LRRK2 require sek-1 pmk-1 action  C. elegans homologues MKK6 p38),
                                         vice versa.

                              Disease-linked mutations LRRK2 modify binding
NIH-PA Author Manuscript




                                         Finally, tested mutations LRRK2 associated disease modified
                                         interaction LRRK2 MKKs. HEK 293 cells transfected LRRK2
                                         (WT, G2019S, R1441C, Y1699C I2020T) MKK6. LRRK2                                          immunoprecipitated binding MKK6 quantified immunoblot (Fig. 7A & B).                                          G2019S, R1441C I2020T mutations enhanced binding LRRK2 MKK6,                                          Y1699C mutation did alter binding (Fig. 7 & B). enhanced binding                                          mutant LRRK2 exerted stronger effects MKK6 MKK3 7 binding; R1441C
                                         G2019S mutations did statistically significant increases binding LRRK2
                                         MKK7 (Fig. 7 C & D) MKK3 (Fig. S2 C).

                              DISCUSSION
                                         results indicate LRRK2 interacts MKK3, 6 7. provide multiple
                                         independent lines investigation supporting hypothesis LRRK2 interacts                                          MKKs. LRRK2 binds MKK3, 6, 7, R1441C LRRK2 mutation increases
                                         binding MKK6. LRRK2 phosphorylates MKK3 MKK7 vitro relatively
                                         minor effect MKK6 phosphorylation. expression LRRK2 MKK6 increased
                                         levels protein observed expression protein  
NIH-PA Author Manuscript




                                         expression increased levels LRRK2 MKK6 membrane                                          cytoplasm. Membrane localization LRRK2 MKK6 evident using biochemical
                                         fractionation, immunocytochemical studies. Finally, cellular studies                                          complemented studies showing knockdown deletion MKK6 (sek-1) p38
                                         (pmk-1) C. elegans abrogates LRRK2-mediated protection rotenone toxicity,
                                         demonstrates endogenous MKK6 required LRRK2 function. 
                                         data point role MKKs JNK/p38 pathways LRRK2 function.                                          data consistent hypothesis interaction MKKs LRRK2 affects
                                         different biochemical processes, protein translation  degradation) membrane
                                         association.

                                         observed robust binding LRRK2 MKK3, 6 7, MKK4. structures
                                         MKK4 MKK2 differ N-termini, conserved,                                          short sequences (MKK4 amino acids 193-9, 278â€“283 329-35) conserved 
                                              J Neurochem. Author manuscript; available PMC 2010 April 20.
                            Hsu et al.                                                                                          Page 8


                                        MKK 3, 6 7 MKK4. Future studies determine                                         domains contribute specificity LRRK2 binding. domains LRRK2 regulate
                                        binding identified deletion studies showed similar binding patterns MKK3,
NIH-PA Author Manuscript




                                        6 7. MKKs bound LRRK2 deletion constructs containing COR                                         kinase domains, LRR domain LRRK2. studies highlight                                         importance ROC COR domains. ROC domain LRRK2 contributes                                         homo-dimerization (Greggio et al. 2008), sequences outside ROC-COR bi-
                                        domain required dimer formation (Klein et al. 2009, Greggio et al. 2008).
                                        LRRK2 binds CHIP, ubiquitin ligase binds Hsp-70, interaction occurs                                         COR ROC domains (Ko et al. 2009). ROC COR domains  kinase
                                        domain) necessary phosphorylation moesin (Jaleel et al. 2007).                                         putative LRRK2 binding proteins identified, including Fas binding
                                        protein, Hsp90, 4E-BP JIP1-4, studies analyzed domain
                                        requirements binding (Ho et al. 2009, Dachsel et al. 2007, Imai et al. 2008, Hsu et al.
                                        2009).  ROC COR domains appear play particularly important roles                                         association LRRK2 proteins.

                                        study identifies new group proteins regulate levels LRRK2                                         membrane association LRRK2. expressing LRRK2 MKKs increased total
                                        levels LRRK2 MKKs (fig. 1, 2 & 4). hypothesize changes regulated
                                        level translation degradation expression increased NIH-PA Author Manuscript




                                        transgenic proteins (LRRK2 MKKs), regulated constitutive CMV
                                        promoter, endogenous MKK6 (fig. 1). Prior studies indicate LRRK2 binds                                         protein 4E-BP, inhibits protein translation, stimulating 4E-BP                                         rapamycin suppress phenotypes associated PD (Imai et al. 2008,Tain et al. 2009).
                                        recently confirmed LRRK2 phosphorylates 4E-BP, phosphorylation
                                        observed vitro, cell systems (Kumar et al. 2009). Interestingly,                                         p38, potential effector MKK activity convincing kinase                                         LRRK2 4EBP. direct mediated intermediate kinases, interaction
                                        LRRK2 4E-BP provides link LRRK2 protein translation                                         contribute changes LRRK2 levels associated expressing MKKs.                                         studies needed clarify LRRK2 complex includes MKKs 4E-
                                        BP proteins linked protein translation.

                                        LRRK2 localizes membranes significance localization poorly
                                        understood (West et al. 2005, Biskup et al. 2006, Higashi et al. 2007). studies suggest
                                        transfecting LRRK2 MKK6  possibly MKKs) increases membrane
                                        association MKK6. increase LRRK2 membrane localization
                                        remains ambiguous increase total LRRK2 associated MKK 
NIH-PA Author Manuscript




                                        transfection account apparent increase LRRK2 membrane localization.
                                        hypothesis association LRRK2 membranes regulate
                                        localization proteins new, multiple prior studies provide clear evidence                                         localization LRRK2 membranes. Studies Hatana et al. (Hatano et al. 2007)
                                        indicate LRRK2 localizes plasma membrane lipid rafts, studies                                         groups demonstrate LRRK2 associates organelle membranes (West et al.
                                        2005, Biskup et al. 2006, Higashi et al. 2007). observation LRRK2 regulates MKK
                                        localization complements recent studies laboratory indicating LRRK2
                                        binds JIP1 â€“ 4, scaffold proteins bring MKKs MAPKs (e.g.,
                                        JNK p38) (Hsu et al. 2009). JIPs appear function directing MAP kinase
                                        signaling complex different sites cells (Whitmarsh 2006). hypothesize                                         LRRK2 acts complex facilitate localization MKK/MAPK proteins                                         sites stress.



                                             J Neurochem. Author manuscript; available PMC 2010 April 20.
                            Hsu et al.                                                                                          Page 9


                                        actions LRRK2 appear differ RIPs MLKs, despite moderate
                                        homology proteins. RIPs MLKs thought function multi-tiered
                                        phosphorylating appropriate downstream MAPKK, turn
NIH-PA Author Manuscript




                                        phosphorylates activates JNK p38 regulate specific transcription factors                                         cellular responses. contrasts relatively modest phosphorylation                                         MKKs LRRK2. able repeat observations Gloeckner et al showing                                         LRRK2 phosphorylates MKKs 3, 6 7.  concentration MKKs needed                                         elicit phosphorylation MKKs quite high (40-fold greater LRRK2),                                         suggests small fraction MKK actually phosphorylated LRRK2,
                                        reminiscent recent observations low level 4EBP phosphorylation LRRK2.                                         low level phosphorylation explain changes MKK, JNK p38
                                        phosphorylation evident transfection proteins.

                                        modest effects kinase domain consistent results observed C. elegans
                                        Drosophila (Saha et al. 2009, Wang et al. 2008). C. elegans, kinase
                                        dead LRRK2 functional protected toxicity induced rotenone,
                                        WT LRRK2 (Saha et al. 2009). Similar results observed                                         Drosophila, Wang colleagues observed deletion kinase domain                                         Drosophila LRRK2 homolog protected toxicity induced rotenone paraquat
                                        (Wang et al. 2008). studies suggest LRRK2 exhibits multiple physiological
                                        actions, independent kinase activity. type kinase-independent
NIH-PA Author Manuscript




                                        regulation similar observed RIP kinases, closest homologues                                         LRRK2 (Festjens et al. 2007). RIP-1 activates NF-kB response DNA damage                                         mechanism does require RIP-1 kinase activity (Festjens et al. 2007).                                          pathways regulated RIP-1, TNF-receptor/MEK-1/ERK cascade, require
                                        RIP-1 kinase activity (Festjens et al. 2007).

                                        Studies LRRK2 beginning illuminate functional role LRRK2. Experiments                                         mammalian cells indicate LRRK2 potentiates peroxide-induced neurotoxicity                                         kinase dependent manner (West et al. 2007). studies vivo support role LRRK2
                                        response stress, differ details (Saha et al. 2009, Wang et al. 2008).                                         observed WT LRRK2 protects toxicity induced rotenone paraquat C.
                                        elegans, inhibit complex electron transport chain (Saha et al. 2009).
                                        G2019S R1441C LRRK2 mutants reduced protection mitochondrial
                                        inhibition actually increase degeneration dopaminergic neurons basal
                                        conditions mitochondrial inhibition (Saha et al. 2009). LRRK2 expression C.
                                        elegans complements function lrk-1, homolog LRRK2 C. elegans,                                         knockdown deletion lrk-1 potentiates rotenone toxicity (Saha et al. 2009, Sakaguchi-
                                        Nakashima et al. 2007). Wang colleagues observed similar results, study
NIH-PA Author Manuscript




                                        pointed selective role LRRK2 protecting toxicity induced hydrogen
                                        peroxide (Wang et al. 2008). selective toxicity observe mutant LRRK2                                         consistent studies transgenic mice, rats neuronal SY5Y cells suggest
                                        mutant forms LRRK2 toxic WT LRRK2 (Li et al. 2009, Greggio
                                        et al. 2006, Greggio et al. 2007, Macleod et al. 2006, Smith et al. 2005). current
                                        manuscript, extend observations demonstrating LRRK2-mediated stress
                                        response requires activity MKK6/sek-1 p38/pmk-1 pathway, blocking
                                        pathway abrogated protection LRRK2 C. elegans. Knockdown MKK6/sek-1                                         p38/pmk-1 protects rotenone-mediated toxicity non-transgenic nematodes,                                         brings protection level equal seen LRRK2 expression. Conversely,
                                        knockdown MKK6/sek-1 p38/pmk-1 LRRK2 nematodes effectively abrogates                                         protection LRRK2 brings protection level non-transgenic nematodes.
                                        data consistent hypothesis LRRK2 acts mechanism involving
                                        MKK6/sek-1 p38/pmk-1.


                                             J Neurochem. Author manuscript; available PMC 2010 April 20.
                            Hsu et al.                                                                                                              Page 10


                                          MAPK cascade contributes disease remains unclear. current study,                                           G2019S, R1441C I2020T LRRK2 mutant constructs showed increased binding                                           MKKs, Y1699C LRRK2 mutation did statistically significant
NIH-PA Author Manuscript




                                          increase binding. Binding MKK3 7 did statistically significant changes,
                                          apparent mutation-linked differences raises possibility future studies
                                          using larger sample sizes identify significant effects. results parallel                                           binding studies, identify specific binding interaction altered large
                                          panel disease-linked mutations (Imai et al. 2008, Ko et al. 2009, Ho et al. 2009, Dachsel
                                          et al. 2007, Jaleel et al. 2007); (Hsu et al. 2009). Studies phosphorylation inclusion
                                          formation effects consistent disease-linked mutations
                                          (Greggio et al. 2006, Greggio et al. 2007, Smith et al. 2005, Gloeckner et al. 2009, Greggio
                                          et al. 2008, Ito et al. 2007, West et al. 2005). notable exception trend binding
                                          LRRK2 Fas-associated protein, does robust increases binding                                           panel different LRRK2 mutations (Ho et al. 2009). Fas-associated protein
                                          utilizes signal transduction pathway mediated RIP kinases mediated MKKs
                                          (Festjens et al. 2007).  Fas-mediated pathway involving MKKs contribute                                           pathophysiology PD, information needed conclusion
                                          stated strong confidence.

                                          increasing evidence linking LRRK2 function stress response, particular                                           MAPK pathways, illuminates biological function ultimately reveal
NIH-PA Author Manuscript




                                          biological mechanisms linked PD. studies shown p38 JNK actions                                           crucial regulation cell death PD models. CHOP/Gadd153, transcription factor
                                          downstream p38, regulated 6-OHDA 1-methyl-4-phenylpyridinium
                                          (MPP+) treatments dopaminergic cell line. Manganese 6-OHDA treatments                                           strongly activate p38 JNK pathways increasing phosphorylated p38 c-jun (Holtz
                                          & O'Malley 2003). c-Jun activated dopaminergic neurons PD patients 1-
                                          methyl-4-phenyl-1,2,4,6 tetrahydropyridine (MPTP) mouse model PD. JNK2 JNK3,
                                          JNK 1, required MPTP-induced c-jun activation elimination
                                          JNK2 JNK3 prevent neurodegeneration improve motor function MPTP-treated
                                          mice (Hunot et al. 2004). Inhibitors JNK MLK CEP1347 shown                                           protective various vitro vivo PD models (Roux et al. 2002, Silva et al. 2005).
                                          data suggest role LRRK2 p38 JNK cascades response stresses
                                          related PD.

                              Supplementary Material
                                          Refer Web version PubMed Central supplementary material.
NIH-PA Author Manuscript




                              Acknowledgments
                                          thank Roger Davis generosity sharing MKK plasmids, Leonard Petrucelli valuable
                                          advice. thank Shelley Russek Ramona Faris assistance luciferase assays, Andrew
                                          Ferree help editing manuscript. work supported NIEHS ES15567, NINDS NS41786,                                           Alzheimer Association Michael J. Fox Foundation (B.W.). research supported                                           Intramural Research Program NIH, National Institute Aging, Z01AG000948 (M.R.C.).


                              ABBREVIATIONS
                                        COR              carboxy-terminal Ras
                                        JIP              c-Jun interacting protein
                                        JNK              c-Jun kinase



                                                J Neurochem. Author manuscript; available PMC 2010 April 20.
                            Hsu et al.                                                                                                   Page 11




                                        LRRK2           leucine-rich repeat kinase 2
NIH-PA Author Manuscript




                                        MAPK            mitogen-activating protein kinase, MAPK
                                        MKK             MAPK kinase
                                        MLK             mixed-lineage kinase
                                        PD              Parkinsonâ€™s disease
                                        RIP             Receptor Interacting Protein kinase
                                        ROC             Ras complex

                              REFERENCES
                                          Biskup S, Moore DJ, Celsi F, et al. Localization LRRK2 membranous vesicular structures                                             mammalian brain. Ann Neurol 2006;60:557â€“569. [PubMed: 17120249]
                                          Dachsel JC, Taylor JP, Mok SS, et al. Identification potential protein interactors Lrrk2.
                                            Parkinsonism Relat Disord 2007;13
                                          Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P. RIP1, kinase crossroads cell's
                                            decision live die. Cell Death Differ 2007;14:400â€“410. [PubMed: 17301840]
                                          Gallo KA, Johnson GL. Mixed-lineage kinase control JNK p38 MAPK pathways. Nat Rev Mol
NIH-PA Author Manuscript




                                            Cell Biol 2002;3:663â€“672. [PubMed: 12209126]
                                          Garrington TP, Johnson GL. Organization regulation mitogen-activated protein kinase signaling
                                            pathways. Curr Opin Cell Biol 1999;11:211â€“218. [PubMed: 10209154]
                                          Gloeckner CJ, Schumacher  Boldt K, Ueffing M. Parkinson disease-associated protein kinase
                                            LRRK2 exhibits MAPKKK activity phosphorylates MKK3/6 MKK4/7, vitro. J
                                            Neurochem 2009;109:959â€“968. [PubMed: 19302196]
                                          Greggio E, Cookson MR. Leucine-rich repeat kinase 2 mutations Parkinson's disease:                                             questions. ASN Neuro 2009;1
                                          Greggio E, Jain S, Kingsbury  et al. Kinase activity required toxic effects mutant
                                            LRRK2/dardarin. Neurobiol Dis 2006;23:329â€“341. [PubMed: 16750377]
                                          Greggio E, Lewis PA, van der Brug MP, Ahmad R, Kaganovich  Ding J, Beilina  Baker AK,
                                            Cookson MR. Mutations LRRK2/dardarin associated Parkinson disease toxic                                             equivalent mutations homologous kinase LRRK1. J Neurochem 2007;102:93â€“102. [PubMed:
                                            17394548]
                                          Greggio E, Zambrano  Kaganovich  et al. Parkinson disease-associated leucine-rich repeat
                                              kinase 2 (LRRK2) dimer undergoes intramolecular autophosphorylation. J Biol Chem
                                              2008;283:16906â€“16914. [PubMed: 18397888]
                                          Hatano T, Kubo S, Imai S, Maeda M, Ishikawa K, Mizuno Y, Hattori N. Leucine-rich repeat kinase 2
NIH-PA Author Manuscript




                                              associates lipid rafts. Hum Mol Genet 2007;16:678â€“690. [PubMed: 17341485]
                                          Higashi S, Moore DJ, Colebrooke  Biskup S, Dawson VL, Arai H, Dawson TM, Emson PC.
                                              Expression localization Parkinson's disease-associated leucine-rich repeat kinase 2                                               mouse brain. J Neurochem 2007;100:368â€“381. [PubMed: 17101029]
                                          Ho CC, Rideout HJ, Ribe E, Troy CM, Dauer WT. Parkinson disease protein leucine-rich repeat
                                              kinase 2 transduces death signals Fas-associated protein death domain caspase-8                                               cellular model neurodegeneration. J Neurosci 2009;29:1011â€“1016. [PubMed: 19176810]
                                          Holtz WA, O'Malley KL. Parkinsonian mimetics induce aspects unfolded protein response death
                                              dopaminergic neurons. J Biol Chem 2003;278:19367â€“19377. [PubMed: 12598533]
                                          Hsu C, Chan D, Wolozin B. LRRK2 Stress Response: Interaction MKKs JIPs.
                                              Neurodegener Dis. 2009  press).
                                          Hunot S, Vila M, Teismann P, Davis RJ, Hirsch EC, Przedborski S, Rakic P, Flavell RA. JNK-
                                              mediated induction cyclooxygenase 2 required neurodegeneration mouse model                                               Parkinson's disease. Proc Natl Acad Sci U S 2004;101:665â€“670. [PubMed: 14704277]



                                                J Neurochem. Author manuscript; available PMC 2010 April 20.
                            Hsu et al.                                                                                                 Page 12


                                        Iaccarino C, Crosio C, Vitale C, Sanna G, Carri MT, Barone P. Apoptotic mechanisms mutant
                                            LRRK2-mediated cell death. Hum Mol Genet 2007;16:1319â€“1326. [PubMed: 17409193]
                                        Imai Y, Gehrke S, Wang HQ, Takahashi R, Hasegawa K, Oota E, Lu B. Phosphorylation 4E-BP NIH-PA Author Manuscript




                                            LRRK2 affects maintenance dopaminergic neurons Drosophila. Embo J 2008;27:2432â€“
                                            2443. [PubMed: 18701920]
                                        Ito G, Okai T, Fujino G, Takeda K, Ichijo H, Katada T, Iwatsubo T. GTP Binding Essential                                             Protein Kinase Activity LRRK2, Causative Gene Product Familial Parkinson's Disease.
                                            Biochemistry 2007;46:1380â€“1388. [PubMed: 17260967]
                                        Jaleel M, Nichols RJ, Deak M, Campbell DG, Gillardon F, Knebel  Alessi DR. LRRK2
                                            phosphorylates moesin threonine-558: characterization Parkinson's disease mutants
                                            affect kinase activity. Biochem J 2007;405:307â€“317. [PubMed: 17447891]
                                        Kamath RS, Martinez-Campos M, Zipperlen P, Fraser AG, Ahringer J. Effectiveness specific RNA-
                                            mediated interference ingested double-stranded RNA Caenorhabditis elegans. Genome
                                            Biol 2001;2 RESEARCH0002.
                                        Klein CL, Rovelli G, Springer W, Schall C, Gasser T, Kahle PJ. Homo- heterodimerization                                             ROCO kinases: LRRK2 kinase inhibition LRRK2 ROCO fragment. J Neurochem
                                            2009;111:703â€“715. [PubMed: 19712061]
                                        Ko HS, Bailey R, Smith WW, et al. CHIP regulates leucine-rich repeat kinase-2 ubiquitination,
                                            degradation, toxicity. Proc Natl Acad Sci U S 2009;106:2897â€“2902. [PubMed: 19196961]
                                        Kumar  Greggio E, Beilina  Kaganovich  Chan D, Wolozin B, Cookson M. Parkinsonâ€™s
                                            disease associated LRRK2 exhibits weaker vitro phosphorylation 4E-BP compared                                             autophosphorylation. PLoS  2009  press).
NIH-PA Author Manuscript




                                        Lewis PA, Greggio E, Beilina  Jain S, Baker  Cookson MR. R1441C mutation LRRK2
                                            disrupts GTP hydrolysis. Biochem Biophys Res Commun 2007;357:668â€“671. [PubMed:
                                            17442267]
                                        Li X, Tan YC, Poulose S, Olanow CW, Huang XY, Yue  Leucine-rich repeat kinase 2 (LRRK2)/
                                            PARK8 possesses GTPase activity altered familial Parkinson's disease R1441C/G
                                            mutants. J Neurochem 2007;103:238â€“247. [PubMed: 17623048]
                                        Li Y, Liu W, Oo TF, et al. Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal
                                            features Parkinson's disease. Nat Neurosci. 2009
                                        Liou AK, Leak RK, Li L, Zigmond MJ. Wild-type LRRK2 mutant attenuates stress-induced
                                            cell death ERK pathway. Neurobiol Dis 2008;32:116â€“124. [PubMed: 18675914]
                                        Livak KJ, Schmittgen TD. Analysis relative gene expression data using real-time quantitative PCR
                                            2(âˆ’Delta Delta C(T)) Method. Methods 2001;25:402â€“408. [PubMed: 11846609]
                                        Macleod D, Dowman J, Hammond R, Leete T, Inoue K, Abeliovich  Familial Parkinsonism
                                            Gene LRRK2 Regulates Neurite Process Morphology. Neuron 2006;52:587â€“593. [PubMed:
                                            17114044]
                                        Olanow CW, Stern MB, Sethi K. scientific clinical basis treatment Parkinson
                                            disease (2009). Neurology 2009;72:S1â€“S136. [PubMed: 19470958]
NIH-PA Author Manuscript




                                        Plowey ED, Cherra SJ 3rd, Liu YJ, Chu CT. Role autophagy G2019S-LRRK2-associated neurite
                                            shortening differentiated SH-SY5Y cells. J Neurochem 2008;105:1048â€“1056. [PubMed:
                                            18182054]
                                        Roux PP, Dorval G, Boudreau M, Angers-Loustau  Morris SJ, Makkerh J, Barker PA. K252a                                             CEP1347 neuroprotective compounds inhibit mixed-lineage kinase-3 induce
                                            activation Akt ERK. J Biol Chem 2002;277:49473â€“49480. [PubMed: 12388555]
                                        Saha S, Guillily M, Ferree  et al. LRRK2 modulates vulnerability mitochondrial dysfunction C.
                                            elegans. J. Neuroscience. 2009 press.
                                        Sakaguchi-Nakashima  Meir JY, Jin Y, Matsumoto K, Hisamoto N. LRK-1, C. elegans PARK8-
                                            related kinase, regulates axonal-dendritic polarity SV proteins. Curr Biol 2007;17:592â€“598.
                                            [PubMed: 17346966]
                                        Silva RM, Kuan CY, Rakic P, Burke  Mixed lineage kinase-c-jun N-terminal kinase signaling
                                            pathway: new therapeutic target Parkinson's disease. Mov Disord 2005;20:653â€“664. [PubMed:
                                            15719422]



                                             J Neurochem. Author manuscript; available PMC 2010 April 20.
                            Hsu et al.                                                                                                 Page 13


                                        Smith WW, Pei  Jiang H, Dawson VL, Dawson TM, Ross CA. Kinase activity mutant LRRK2
                                            mediates neuronal toxicity. Nat Neurosci 2006;9:1231â€“1233. [PubMed: 16980962]
                                        Smith WW, Pei  Jiang H, Moore DJ, Liang Y, West AB, Dawson VL, Dawson TM, Ross CA.
NIH-PA Author Manuscript




                                            Leucine-rich repeat kinase 2 (LRRK2) interacts parkin mutant LRRK2 induces neuronal
                                            degeneration. Proc Natl Acad Sci U S 2005;102:18676â€“18681. [PubMed: 16352719]
                                        Tain LS, Mortiboys H, Tao RN, Ziviani E, Bandmann O, Whitworth AJ. Rapamycin activation 4E-
                                            BP prevents parkinsonian dopaminergic neuron loss. Nat Neurosci 2009;12:1129â€“1135. [PubMed:
                                            19684592]
                                        Tanaka-Hino M, Sagasti  Hisamoto N, Kawasaki M, Nakano S, Ninomiya-Tsuji J, Bargmann CI,
                                            Matsumoto K. SEK-1 MAPKK mediates Ca2+ signaling determine neuronal asymmetric
                                            development Caenorhabditis elegans. EMBO Rep 2002;3:56â€“62. [PubMed: 11751572]
                                        Wang D, Tang B, Zhao G, Pan Q, Xia K, Bodmer R, Zhang  Dispensable role Drosophila
                                            ortholog LRRK2 kinase activity survival dopaminergic neurons. Mol Neurodegener
                                            2008;3:3. [PubMed: 18257932]
                                        West AB, Moore DJ, Biskup S, Bugayenko  Smith WW, Ross CA, Dawson VL, Dawson TM.
                                            Parkinson's disease-associated mutations leucine-rich repeat kinase 2 augment kinase activity.
                                            Proc Natl Acad Sci U S 2005;102:16842â€“16847. [PubMed: 16269541]
                                        West AB, Moore DJ, Choi C, et al. Parkinson's disease-associated mutations LRRK2 link enhanced
                                            GTP-binding kinase activities neuronal toxicity. Hum Mol Genet 2007;16:223â€“232.
                                            [PubMed: 17200152]
                                        Whitmarsh AJ. JIP family MAPK scaffold proteins. Biochem Soc Trans 2006;34:828â€“832.
                                            [PubMed: 17052208]
NIH-PA Author Manuscript




                                        Zimprich  Biskup S, Leitner P, et al. Mutations LRRK2 Cause Autosomal-Dominant
                                            Parkinsonism Pleomorphic Pathology. Neuron 2004;44:601â€“607. [PubMed: 15541309]
NIH-PA Author Manuscript




                                             J Neurochem. Author manuscript; available PMC 2010 April 20.
                            Hsu et al.                                                                                   Page 14
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                        Fig. 1.
                                        LRRK2 binds MKK6, pathogenic mutations LRRK2 increase binding                                         LRRK2 MKK6. LRRK2 activates p38 pathway.   LRRK2 immunoprecipitates
                                        MKK6 HEK-293FT cells. (B) LRRK2 kinase COR domains essential NIH-PA Author Manuscript




                                        sufficient interaction MKK6. (C) Dominant negative K82A mutation MKK6
                                        reduces MKK6 binding LRRK2. experiments performed times. D.)
                                        Eluate anti-V5 column shows association endogenous MKK6 LRRK2
                                        (V5). Levels protein lysates shown 




                                              J Neurochem. Author manuscript; available PMC 2010 April 20.
                            Hsu et al.                                                                                    Page 15
NIH-PA Author Manuscript




                                        Fig. 2.
                                        LRRK2 binds MKK7 MKK4 activates JNK pathway.   LRRK2 
                                        immunoprecipitates MKK7 MKK4 HEK-293FT cells. (B) LRRK2 kinase
                                        COR domains essential sufficient interaction MKK7. (C) Dominant
                                        negative K82A mutation MKK7 reduces MKK7 binding LRRK2. experiments                                         performed times.
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                              J Neurochem. Author manuscript; available PMC 2010 April 20.
                            Hsu et al.                                                                                   Page 16
NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                        Fig. 3.
                                        LRRK2 stimulates MKK phosphorylation.  Recombinant MKK3, 6 7 (Flag-tagged)
                                        incubated Â± LRRK2 (WT, G2019S KD, GST-tagged), presence kinase
                                        buffer 32P-ATP. B. Coomassie gel showing purity recombinant MKK3, 6                                         7. C & D. Quantification MKK phosphorylation (C) LRRK2 autophosphorylation (D)
                                        densitometry. Error bars SEM independent experiments.




                                              J Neurochem. Author manuscript; available PMC 2010 April 20.
                            Hsu et al.                                                                                    Page 17
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                        Fig. 4.
                                        Expressing LRRK2 increases level MKK6 membrane fraction.   WT
                                        G2019S LRRK2 increased level membrane MKK6. (B) Quantification indicated
                                        level membrane MKK6 increased 4-fold expressed                                         LRRK2 (*p<0.05; N=3, compared WT MKK6). significant difference                                         level membrane MKK6 WT G2019S LRRK2-transfected samples.                                         level MKK6 membrane fraction normalized level MKK6 total
                                        lysate, compared samples transfected Â± LRRK2. Experiments repeated
                                        times HEK-293FT cells. (C) expression WT G2019S LRRK2 WT
NIH-PA Author Manuscript




                                        MKK6 increased levels MKK6 present plasma membrane, shown 
                                        localization amyloid precursor protein (APP). arrows point LRRK2/APP 
                                        localization. Bar, 15 Âµm. experiments performed times.




                                              J Neurochem. Author manuscript; available PMC 2010 April 20.
                            Hsu et al.                                                                                   Page 18
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                        Fig. 5.
                                        expression LRRK2 MKK6 leads localization. HEK 293 cells 
                                        transfected LRRK2 (WT G2019S) Â± MKK6 (WT dominant negative).                                         proteins subsequently identified immunocytochemistry. WT G2019S LRRK2
                                        localize WT MKK6. localization reduced dominant negative MKK6,
                                        suggesting importance MKK6 function interaction LRRK2. arrows
                                        point areas LRRK2 membrane localization. Bar, 15 Âµm. experiments                                         performed times.
NIH-PA Author Manuscript




                                              J Neurochem. Author manuscript; available PMC 2010 April 20.
                            Hsu et al.                                                                                          Page 19
NIH-PA